Cancerify Logo

Dr. Carol Aghajanian

160 East 53rd Street, New York, NY 10022
646‑888‑4217

Dr. Carol Aghajanian, MD, is a highly accomplished gynecologic medical oncologist who serves as Chief of the Gynecologic Medical Oncology Service and Avon Chair in Gynecologic Oncology Research at Memorial Sloan Kettering Cancer Center (MSKCC). An alumna of SUNY Downstate Medical College (MD, cum laude, Alpha Omega Alpha), she completed internal medicine residency at Mount Sinai Hospital followed by fellowship training in hematology and medical oncology at MSKCC. Board-certified in Internal Medicine and Medical Oncology, she provides expert care for women with ovarian, uterine, cervical, vaginal, vulvar, and gestational trophoblastic cancers—offered through both in-person and telehealth consultations.

She is highly regarded for her leadership in early-phase drug development and pivotal clinical trials in gynecologic cancers. As co-principal investigator for MSK’s Gynecologic Oncology Group (GOG) programs, she has advanced therapies including PARP inhibitors and immune checkpoint blockers in ovarian and endometrial cancer. Her team’s work demonstrated that chemotherapy combined with pembrolizumab improves survival for advanced endometrial cancer, a finding presented at the Society of Gynecologic Oncology annual meeting and published in the New England Journal of Medicine. These contributions have significantly shaped treatment standards and outcomes for women facing advanced gynecologic malignancies.

Beyond her research and clinical practice, she is a passionate mentor and advocate for patient-centered and inclusive care. She credits early mentors for inspiring her focus on collaborative culture and the importance of nurturing the next generation of oncologists. Dr. Aghajanian has received numerous professional honors for clinical excellence. She emphasizes open-minded, science-driven treatment approaches and continues to shape the future of care for women with gynecologic cancers by fostering innovation, mentorship, and equitable access to clinical trials.

Book An Appointment